Eye Health News and Research

Latest Eye Health News and Research

Scientists discover new gene underlying angle-closure glaucoma

Jackson Laboratory researchers and their collaborators have reported their discovery of a gene implicated in an acute and severe form of glaucoma known as angle-closure glaucoma.

3 May 2011

Merck's Phase III study shows efficacy results of tafluprost to treat ocular hypertension

Merck, known as MSD outside the United States and Canada, announced today that new Phase III data showed that patients with open-angle glaucoma or ocular hypertension, who were dosed once-daily with tafluprost, Merck's investigational, preservative-free prostaglandin analogue ophthalmic solution, experienced a reduction in intraocular pressure comparable to patients taking twice-daily preservative-free timolol maleate, a beta-adrenergic antagonist.

3 May 2011

Positive Ellex 2RT data demonstrates efficacy in treatment of early Age-Related Macular Degeneration

Ellex Medical Lasers Limited (ASX:ELX) today announced milestone clinical results for its breakthrough Retinal Regeneration Therapy (Ellex 2RT™) for the treatment of Early Age-Related Macular Degeneration (AMD).

2 May 2011

New insights into structure and function of brain

For more than 50 years, a dominating assumption in brain research was that nerve cells in the cortex of the brain are organised in the form of microscopically small columns. Subsequently, it became a textbook standard that connections are created predominantly between nerve cells within these columns.

2 May 2011

Study: Asking adolescents about their future objectives has significant clinical value

Trying to figure out what's going on inside the mind of an adolescent can be challenging, to say the least. A new study shows that simply asking them what they wish for could be eye-opening.

2 May 2011

ARVO announces 2011 award recipients in retinal research

The Association for Research in Vision and Ophthalmology is pleased to announce its 2011 ARVO Award recipients. These award recipients will be acknowledged at the ARVO 2011 Annual Meeting, May 1 - 5, in Fort Lauderdale, Fla.

2 May 2011

Penn State launches unique oral hygiene approach for dementia patients

Nurses who care for patients with dementia now have a tailored approach to dental hygiene for their charges, thanks to a pilot study by a team of nurses.

2 May 2011

Winners of "On the Road, Off the Phone" public service announcement contest announced

The National Safety Council and FocusDriven today announced the winners of their joint "On the Road, Off the Phone" public service announcement contest, sponsored by The Goodyear Tire and Rubber Co. Because 21 percent of motor vehicle crashes involve cell phone conversations, NSC and FocusDriven asked aspiring filmmakers to create short videos explaining the dangers of cell phone conversations while driving.

30 Apr 2011

Mediaplanet releases Kidney Health report to targeted markets in USA

On April 29, 2011, Mediaplanet Publishing released a Kidney Health report to targeted markets in USA Today. The report will be distributed to 1 million readers with contributions from Kidney Cancer Association, National Kidney Foundation, Fresenius Medical Care North America, UKidney, Medical Education Institute, and National Kidney Registry.

30 Apr 2011

Merck first quarter sales increase 1% to $11.6 billion for 2011

Merck, known as MSD outside the United States and Canada, today announced financial results for the first quarter of 2011.

30 Apr 2011

ARVO announces 2011 distinguished fellows in ophthalmology research

The Association for Research in Vision and Ophthalmology is pleased to announce this year's class of distinguished fellows. The title of Fellow of ARVO recognizes members for their accomplishments, leadership and contributions to the Association.

30 Apr 2011

LSI announces publication of Emerging Medtech Companies report

Life Science Intelligence, a leading medical technology market intelligence firm, has announced the publication of its Report on Emerging Medtech Companies in Q1 2011.

30 Apr 2011

Health Canada approves Eli Lilly's Cymbalta for chronic low back pain treatment

Eli Lilly Canada announced today that Health Canada has approved Cymbalta for the management of chronic low back pain.

30 Apr 2011

Gene therapy approach using CD59 shows promise against AMD: Study

A gene therapy approach using a protein called CD59, or protectin, shows promise in slowing the signs of age-related macular degeneration, according to a new in vivo study by researchers at Tufts University School of Medicine.

30 Apr 2011

Avastin, Lucentis are equally effective for age-related macular degeneration treatment

Age-related macular degeneration, a disease that damages the retina and can destroy central vision, affects approximately 1.6 million Americans. For the past five years, there has been active debate over treatment options for AMD patients because ophthalmologists have not had accurate data regarding the true efficacy of the most commonly used medication.

29 Apr 2011

Researchers report Avastin is effective as Lucentis for AMD treatment

Researchers are reporting results from the first year of a two-year clinical trial that Avastin, a drug approved to treat some cancers and that is commonly used off-label to treat age-related macular degeneration, is as effective as the Food and Drug Administration-approved drug Lucentis for the treatment of AMD.

29 Apr 2011

5 minute Autism detection test

According to a study published Thursday, a brief screening in a pediatrician's office can detect autism-like symptoms in children as young as 12 months old, giving them an important head start on treatment. The screening test used in the study also flagged some babies who later turned out to be developing normally, raising a false alarm for families. But early diagnosis and treatment of autism and other developmental delays are thought to improve outcomes, and researchers said the benefits of early intervention outweighed the downsides.

29 Apr 2011

STAAR Surgical receives CE Mark approval for nanoFLEX Collamer IOL lens

STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced CE Mark approval for its nanoFLEX Collamer Single Piece IOL which can be injected through a 2.2 mm incision with the nanoPOINT Injector System.

28 Apr 2011

E-Cigarette company welcomes FDA regulation

The recent ruling in the Sottera, Inc. v. Food & Drug Administration case has once again brought the E-Cigarette industry into the spotlight and Green Nicotine Electronic Cigarettes could not be better prepared. Many electronic cigarette companies will have to scramble to prepare for FDA regulation, but Green Nicotine Electronic Cigarettes has been prepared for these types of regulations since 2009.

28 Apr 2011

Positive results from Shire's Vyvanse clinical trial in schizophrenia

Shire plc, the global specialty biopharmaceutical company, today announced positive results from a signal-finding study of Vyvanse(R) Capsules assessing its effect in a prospective examination of adults with negative symptom predominant schizophrenia.

28 Apr 2011